Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1203 participants.
Also called NCT01445613
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,203 participants
- Sponsor
- Registry
-
NCT01445613
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01445613. Allocation not applicable; no masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2014-12 (actual). Results posted on 2016-04-12.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
- Acronym
- CANOPY
- Condition
- Carotid Artery Disease
- Condition
- Stroke
- Condition
- Amaurosis Fugax
- Intervention (Device)
- RX Acculink Carotid Stent System (RX Acculink)
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct01445613- Content hash
848bca3d8a5551bad2bf41d614e764570eb2af3d3ec4924bb45af43bffa1c583